Sylvia Sura‐Trueba

530 total citations
7 papers, 343 citations indexed

About

Sylvia Sura‐Trueba is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Sylvia Sura‐Trueba has authored 7 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Sylvia Sura‐Trueba's work include Thyroid Disorders and Treatments (4 papers), Congenital heart defects research (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Sylvia Sura‐Trueba is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Congenital heart defects research (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Sylvia Sura‐Trueba collaborates with scholars based in France, Russia and Ireland. Sylvia Sura‐Trueba's co-authors include Aurore Carré, Mireille Castanet, Gabor Szinnai, Juliane Léger, Michel Polak, Mirosław P. Polak, Cyril Goizet, Elodie Tron, M.L. Moutard and Serge Romana and has published in prestigious journals such as Human Molecular Genetics, Cell Death and Disease and Human Genetics.

In The Last Decade

Sylvia Sura‐Trueba

7 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Sura‐Trueba France 7 199 145 116 61 59 7 343
Hironobu Sasano Japan 10 126 0.6× 85 0.6× 68 0.6× 14 0.2× 70 1.2× 19 333
Elodie Tron France 8 219 1.1× 127 0.9× 144 1.2× 104 1.7× 87 1.5× 10 388
Cristina Ghervan Romania 9 119 0.6× 132 0.9× 132 1.1× 12 0.2× 55 0.9× 30 360
Marjan M. Nezarati Canada 10 232 1.2× 198 1.4× 34 0.3× 27 0.4× 57 1.0× 17 447
Andrew Lane United States 10 257 1.3× 203 1.4× 81 0.7× 42 0.7× 51 0.9× 22 428
Nancy Gagné Canada 6 121 0.6× 79 0.5× 150 1.3× 23 0.4× 137 2.3× 10 308
Yoshihiro Tanno Japan 9 137 0.7× 39 0.3× 85 0.7× 25 0.4× 18 0.3× 11 389
Wee Teik Keng Malaysia 11 183 0.9× 183 1.3× 23 0.2× 50 0.8× 100 1.7× 20 420
Anita S. Goldhar United States 8 203 1.0× 123 0.8× 84 0.7× 26 0.4× 14 0.2× 9 387
Linda Gibbs France 8 154 0.8× 105 0.7× 11 0.1× 21 0.3× 31 0.5× 12 335

Countries citing papers authored by Sylvia Sura‐Trueba

Since Specialization
Citations

This map shows the geographic impact of Sylvia Sura‐Trueba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Sura‐Trueba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Sura‐Trueba more than expected).

Fields of papers citing papers by Sylvia Sura‐Trueba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Sura‐Trueba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Sura‐Trueba. The network helps show where Sylvia Sura‐Trueba may publish in the future.

Co-authorship network of co-authors of Sylvia Sura‐Trueba

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Sura‐Trueba. A scholar is included among the top collaborators of Sylvia Sura‐Trueba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Sura‐Trueba. Sylvia Sura‐Trueba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sullivan, Graeme P., Conor M. Henry, Danielle M. Clancy, et al.. (2018). Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases. Cell Death and Disease. 9(3). 378–378. 39 indexed citations
2.
Sullivan, Graeme P., Pavel B. Davidovich, Sylvia Sura‐Trueba, et al.. (2018). Identification of small‐molecule elastase inhibitors as antagonists of IL‐36 cytokine activation. FEBS Open Bio. 8(5). 751–763. 13 indexed citations
3.
Alvarez-Saavedra, Matías, Loreto Carrasco, Sylvia Sura‐Trueba, et al.. (2010). Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Human Molecular Genetics. 19(11). 2177–2190. 37 indexed citations
4.
Carré, Aurore, Gabor Szinnai, Mireille Castanet, et al.. (2009). Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Human Molecular Genetics. 18(12). 2266–2276. 145 indexed citations
5.
Carré, Aurore, Mireille Castanet, Sylvia Sura‐Trueba, et al.. (2007). Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Human Genetics. 122(5). 467–476. 47 indexed citations
6.
Polak, Michel, et al.. (2004). Molecular Mechanisms of Thyroid Dysgenesis. Hormone Research in Paediatrics. 62(Suppl. 3). 14–21. 29 indexed citations
7.
Castanet, Mireille, Sylvia Sura‐Trueba, Aurore Carré, et al.. (2004). Linkage and mutational analysis of familial thyroid dysgenesis demonstrate genetic heterogeneity implicating novel genes. European Journal of Human Genetics. 13(2). 232–239. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026